Safety Study of Erythropoietin (EPO) in Parkinson’s Disease
Condition(s):Parkinson DiseaseLast Updated:October 1, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Parkinson DiseaseLast Updated:October 1, 2019Completed
Condition(s):Anemia; Neoplasms; Chemotherapeutic-Induced AnemiaLast Updated:January 30, 2023Not yet recruiting
Condition(s):Anti-r-HuEpo Associated PRCA SubjectsLast Updated:January 29, 2014Terminated
Condition(s):Anemia, Sickle Cell; Sickle Cell DiseaseLast Updated:July 14, 2023Recruiting
Condition(s):Traumatic Optic NeuropathyLast Updated:March 8, 2024Completed
Condition(s):Chronic Kidney Failure; AnaemiaLast Updated:March 12, 2010Completed
Condition(s):Anemia; Lymphoma; Hematopoietic Stem Cell TransplantationLast Updated:January 5, 2017Unknown status
Condition(s):Acute Renal FailureLast Updated:February 10, 2010Unknown status
Condition(s):Aneurysmal Subarachnoid HemorrhageLast Updated:May 20, 2009Completed
Condition(s):Infant, Newborn; Infant, Low Birth Weight; Infant, Small for Gestational Age; Infant, Premature; Anemia, NeonatalLast Updated:September 26, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.